Clinical Trial Update: The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports on the efficacy and safety of finerenone for treating primary aldosteronism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Primary Aldosteronism, Finerenone | Phase 4 | Status: COMPLETED